ASCO 2023: Research backs chemo-only approach for some rectal cancer patients
These results could mean some patients may respond adequately to FOLFOX and can forego radiation before surgery.
ASCO 2023: Janssen present positive follow-up data for first in line therapy for lung cancer
Saudi astronaut concludes space experiments on inflammatory diseases
AstraZeneca abandons inflammatory bowel disease drug
Innovent and Merck to carry out cancer combination therapy trial
NeuroMetrix encouraged by Phase II Quell data
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
It’s a match! Connecting patients to clinical trials with AI